Paola Nicoli

*Email*	[email protected]
*Telephone*	0294375119
*Location*	Building 13 Floor Ground Via Adamello 16, Milano

Member of

Research technician with experience in pharmacological studies (pre-clinical development)

Positions

Since Feb 2011: Technician, Department of Experimental Oncology, IEO, Milan, Italy
Dec 1998–May 2010: Senior Technician, Pharmacology and Pre-clinical development, Cell Therapeutics, Milan, Italy
Apr 1996–Dec 1998: Senior Technician, Pharmacology and Pre-clinical development, Boehringer Mannheim Italia, Monza, Italy

Balestrieri C, Alfarano G, Milan M, Tosi V, Prosperini E, Nicoli P, Palamidessi A, Scita G, Diaferia GR, Natoli G

Co-optation of Tandem DNA Repeats for the Maintenance of Mesenchymal Identity.

Cell, 2018
Collino A, Termanini A, Nicoli P, Diaferia G, Polletti S, Recordati C, Castiglioni V, Caruso D, Mitro N, Natoli G, Ghisletti S

Sustained activation of detoxification pathways promotes liver carcinogenesis in response to chronic bile acid-mediated damage.

Plos Genet, 2018
Schauer SN, Carreira PE, Shukla R, Gerhardt DJ, PatriciaGerdes P, Sanchez-Luque FJ , Nicoli P, Michaela Kindlova M, Ghisletti S, Dos Santos A, Rapoud D, Samuel D, Faivre J, Ewing AD, Richardson SR, Faulkner GJ

L1 retrotransposition is a common feature of mammalian hepatocarcinogenesis.

Genome Res, 2018
Rava' M, D'Andrea A, Nicoli P, Gritti I, Donati G, Doni M, Giorgio M, Olivero D, Amati B

Therapeutic synergy between tigecycline and venetoclax in a preclinical model of MYC/BCL2 double-hit B cell lymphoma.

Sci Transl Med, 2018